Author:
Bravaccini Sara,Puccetti Maurizio,Bocchini Martine,Ravaioli Sara,Celli Monica,Scarpi Emanuela,De Giorgi Ugo,Tumedei Maria Maddalena,Raulli Giandomenico,Cardinale Loredana,Paganelli Giovanni
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. http://globocan.iarc.fr/old/FactSheets/cancers/prostate-new.asp , GLOBOCAN2012 (IARC), Section of Cancer Surveillance (20/2/2018).
2. Ross, T., Ahmed, K., Raison, N., Challacombe, B. & Dasgupta, P. Clarifying the PSA grey zone: The management of patients with a borderline PSA. Int J Clin Pract. 70, 950–959 (2016).
3. Ezenwa, E. V. et al. The value of percentage free prostate specific antigen (PSA) in the detection of prostate ancer among patients with intermediate levels of total PSA (4.0–10.0 ng/mL) in Nigeria. Arab J Urol. 10, 394–400 (2012).
4. Epstein, J. I. et al. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System. Am J Surg Pathol. 40, 244–52 (2016).
5. Israeli, R. S., Powell, C. T., Corr, J. G., Fair, W. R. & Heston, W. D. Expression of the prostate-specific membrane antigen. Cancer Res. 54, 1807–1811 (1994).
Cited by
125 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献